# FDA Inspection 767213 - David S. Siegel, M.D. - January 27, 2012

Source: https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/e50b3dd6-bb93-43b3-a624-9f39fd27a1bd
Source feed: FDA_Inspections

> FDA Inspection 767213 for David S. Siegel, M.D. on January 27, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 767213
- Company Name: David S. Siegel, M.D.
- Inspection Date: 2012-01-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1133295 - 2020-11-02](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/4b38d521-79bd-44e0-8335-174e2e31cccf)
- [FDA Inspection 1133295 - 2020-11-02](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/e20125f5-3cce-492f-ad97-a0c80551c771)
- [FDA Inspection 944842 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/b43f7930-3df3-49f3-8b24-8211ee01a289)
- [FDA Inspection 791988 - 2012-07-25](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/69a19cec-8ec9-45a0-9b46-db97b51007b3)

Company: https://www.keypedia.com/companies/david-s-siegel-md/8396ffc1-7d13-4e50-8060-8e3faa29a296

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c